Listed

Strata Critical Medical, Inc.

SRTANasdaqCIK 1779128IndustrialsFiscal year ends Dec 31

Reports and events: 109 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Strata Critical Medical, Inc., Reports and events
FiledFormWhat it isAccession number
2023-05-1116:52 ET8-K5.07 Shareholder vote results0001779128-23-000056
2023-05-1108:51 ET10-QQuarterly reportPeriod 2023-03-310001779128-23-000052
2023-05-1107:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-23-000049
2023-03-3117:28 ETSC 13D/AOwnership report, active investor, amended0001213900-23-025656
2023-03-3016:33 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-23-039190
2023-03-3016:30 ETDEF 14AProxy statementPeriod 2023-05-090001104659-23-039182
2023-03-1618:06 ET10-KAnnual reportPeriod 2022-12-310001779128-23-000029
2023-03-1407:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-23-000025
2023-02-2816:06 ET8-K8.01 Other events0001104659-23-026703
2023-02-1321:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-018851
2023-01-1920:14 ETSC 13DOwnership report, active investor0001213900-23-003570
2023-01-1017:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001779128-23-000007
2022-11-1016:08 ET10-QQuarterly reportPeriod 2022-09-300001779128-22-000112
2022-11-0916:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-22-000109
2022-09-0708:01 ET8-K8.01 Other events0001104659-22-098050
2022-08-0908:04 ET10-QQuarterly reportPeriod 2022-06-300001779128-22-000083
2022-08-0907:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-22-000081
2022-05-1908:01 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-22-062713
2022-05-1007:58 ET10-QQuarterly reportPeriod 2022-03-310001779128-22-000047
2022-05-1007:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-22-000044
2022-05-0614:26 ET8-K5.07 Shareholder vote results0001779128-22-000036
2022-03-2216:05 ETDEF 14AProxy statementPeriod 2022-05-040001104659-22-036550
2022-02-1016:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-22-000020
2022-02-0216:20 ET8-K5.03 Amendment to articles or bylaws0001779128-22-000008
2021-12-2016:44 ET10-KAnnual reportPeriod 2021-09-300001779128-21-000025
2021-12-2007:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-21-000016
2021-12-0208:30 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-145694
2021-09-2416:07 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-119291
2021-09-1708:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-116671
2021-09-0908:16 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-114037
2021-08-1607:04 ET10-QQuarterly reportPeriod 2021-06-300001104659-21-105544
2021-08-1607:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-105537
2021-05-2816:43 ETS-1Registration statement0001104659-21-074243
2021-05-2417:01 ET10-QQuarterly reportPeriod 2021-03-310001104659-21-071301
2021-05-1917:22 ETSC 13DOwnership report, active investor0001193125-21-166752
2021-05-1716:56 ETSC 13DOwnership report, active investor0001104659-21-068215
2021-05-1716:44 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-068193
2021-05-1716:30 ET8-K/A2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001104659-21-068136
2021-05-1319:55 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits0001104659-21-065292
2021-05-1008:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-063444
2021-05-0716:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-063108
2021-05-0706:02 ET10-K/AAnnual report, amendedPeriod 2020-12-310001104659-21-062658
2021-05-0606:00 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-061958
2021-04-2806:09 ET8-K4.02 Non-reliance on financial statements; 8.01 Other events0001104659-21-055907
2021-04-0708:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-047352
2021-03-1808:54 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-038100
2021-03-1006:04 ET10-KAnnual reportPeriod 2020-12-310001104659-21-034054
2021-01-1110:20 ET8-K8.01 Other events0001104659-21-002818
2020-12-1508:51 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-135523
2020-11-1016:01 ET10-QQuarterly reportPeriod 2020-09-300001104659-20-123573

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 9, 2026, 18:10 ET. Listed shows no prices and gives no investment advice.